Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

A cat with severe skin issues improved with dexamethasone and cetirizine.

A sick foal with Rhodococcus equi pneumonia was successfully treated for multiple complications with targeted therapy and careful monitoring.

IVIG and dupilumab effectively improved symptoms in a child with Netherton syndrome.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Some children with localized scleroderma are rarely resistant to methotrexate, and no common profile for resistance was found.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Early referral to a pediatric rheumatologist and thorough evaluation are crucial for treating complex overlap syndromes effectively.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Radiation therapy can worsen Discoid Lupus Erythematosus.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

JAK inhibitors are effective and safe for treating severe alopecia areata.